Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

PAREXEL International Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital Management

Tuesday, September 19, 2017

PAREXEL International Corporation a leading global biopharmaceutical services company announced today that its shareholders at a special meeting held on September 15 2017 in Boston Massachusetts approved the previously announced proposed acquisition of the Company by certain investment funds affilia..

DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL083 for the Treatment of Ovarian Cancer

Tuesday, September 19, 2017

DelMar Pharmaceuticals Inc a biopharmaceutical company focused on the development of new cancer therapies today announced that the US Food and Drug Administration FDA has allowed an additional Investigational New Drug Application IND to study its lead drug candidate VAL083 as a potential treatment f..

Dangote Foundation GBCHealth join forces to build Coalition on Health

Tuesday, September 19, 2017

GLOBE NEWSWIRE

NEW YORK Sept 19 2017 GLOBE NEWSWIRE Dangote Foundation wwwDangotecom and GBCHealth have joined forces toforge a new model of partnership African Business Coalition on Health GBCHealth in Africa Chairman of Dangote Foundation Aliko Dangote shared plans to build an African Business Coalition ..

Akari Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference

Tuesday, September 19, 2017

GLOBE NEWSWIRE

NEW YORK and LONDON Sept 19 2017 GLOBE NEWSWIRE Akari Therapeutics NASDAQAKTX an emerging growth clinicalstage biopharmaceutical company is pleased to announce its Chief Executive Officer Dr David Horn Solomon and Chief Operations Officer Clive Richardson will present at the Cantor Fitzgerald ..

ProQR Receives Orphan Drug Designation from FDA for Drug Candidate QR313 for Dystrophic Epidermolysis Bullosa and will Present Data at two Scientific Conferences

Tuesday, September 19, 2017

GLOBE NEWSWIRE

Key Updates ProQRs drug candidate QR313 for dystrophic epidermolysis bullosa DEB receives orphan drug designation from the FDA representing the fifth program in the Companys pipeline to receive ODD in the USThe Company will be presenting preclinical data for QR313 at two European scientific con..

Madrigal Pharmaceuticals Announces Positive Outcome from PrePlanned DSMB Safety Review and Completion of Enrollment of Phase 2 Study of MGL3196 in Patients with Heterozygous Familial Hypercholesterolemia

Tuesday, September 19, 2017

GLOBE NEWSWIRE

Second DSMB review includes data from both Phase 2 studies in NASH and HeFH Topline results from NASH expected late 2017 and HeFH early 2018 CONSHOHOCKEN Pa Sept 19 2017 GLOBE NEWSWIRE Madrigal Pharmaceuticals Inc NasdaqMDGL today announced that the Companys independent Data Safety Mon..

Cardtronics Survey US Consumers Embrace Freedom to Choose Cash Pay in Multiple Ways

Tuesday, September 19, 2017

GLOBE NEWSWIRE

2017 Health of Cash survey finds 91 percent of consumers used cash in last six months89 percent of consumers like having the ability to use a variety of payment methods61 percent get upset when establishments dont accept cash HOUSTON Sept 19 2017 GLOBE NEWSWIRE Cash has an important place i..

Cytokinetics Announces Dosing of First Patient in Japan in GALACTICHF Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure

Tuesday, September 19, 2017

GLOBE NEWSWIRE

SOUTH SAN FRANCISCO Calif Sept 19 2017 GLOBE NEWSWIRE Cytokinetics Incorporated NasdaqCYTK today announced that the first patient has been dosed in Japan in GALACTICHF Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure the Phase 3 cardiovascul..

Michael T Redman Chairman of the Board and CEO of Oncolix Inc is Featured in a New Audio Interview at SmallCapVoicecom

Tuesday, September 19, 2017

GLOBE NEWSWIRE

AUSTIN Texas Sept 19 2017 GLOBE NEWSWIRE SmallCapVoicecom Inc SCV and Oncolix Inc OTCQBAEPP a clinicalstage biotechnology company developing Prolanta for the treatment of ovarian cancer today announced that a new audio interview with the Company is now available The interview can be heard at h..

Womens Choice Award Announces 2017 Americas Best Hospitals for Cancer Care

Tuesday, September 19, 2017

GLOBE NEWSWIRE

FT LAUDERDALE Fla Sept 19 2017 GLOBE NEWSWIRE The Womens Choice Award Americas trusted referral source for the best in healthcare has announced its 2017 Americas Best Hospitals for Cancer Care The 412 award recipients have met the highest standards for cancer care in the US by the Womens Choic..

Lonza Introduces the New CytoSMART 2 System for Live Cell Imaging

Tuesday, September 19, 2017

Lonza has today introduced the CytoSMART 2 System an updated version of Lonzas popular CytoSMART System for live cell imaging The CytoSMART 2 Device features an advanced optical system and more powerful camera unit which enables researchers to capture higherresolution images of their cell cultures I..

US FDA Approves New Indication for Ipsens Somatuline Depot lanreotide Injection for the Treatment of Carcinoid Syndrome

Monday, September 18, 2017

Ipsen today announced that the US Food and Drug Administration FDA has approved a supplemental indication for Somatuline Depot lanreotide Injection 120 mg for the treatment of carcinoid syndrome when used it reduces the frequency of shortacting somatostatin analogue rescue therapy Somatuline Depo..

ChromaDex to Showcase Healthy Aging Ingredients and Phytochemical Reference Standards at SupplySide West 2017

Monday, September 18, 2017

GLOBE NEWSWIRE

IRVINE Calif Sept 18 2017 GLOBE NEWSWIRE ChromaDex Corp NASDAQCDXC an innovator of sciencebased proprietary health and wellness consumer products and ingredient technologies that promote health longevity announced today that at this years SupplySide West Sept 26 through 28 in Las Vegas it will..

Zephyr Health Expands Zephyr Illuminate Capabilities with Launch of Relationship Analytics

Monday, September 18, 2017

GLOBE NEWSWIRE

SAN FRANCISCO Sept 18 2017 GLOBE NEWSWIRE Zephyr Health the leading InsightsasaService solution provider for Life Sciences companies today announced the launch of Relationship Analytics the latest addition to its awardwinning enterprise solution Zephyr IlluminateTM These new analytic capabilit..

Axsome Therapeutics to Present at Upcoming Investor Conferences

Monday, September 18, 2017

GLOBE NEWSWIRE

NEW YORK Sept 18 2017 GLOBE NEWSWIRE Axsome Therapeutics IncNASDAQAXSM a clinicalstage biopharmaceutical company developing novel therapies for the management of central nervous system CNS disorders today announced thatHerriot Tabuteau MD Axsomes Chief Executive Officer will present a corporat..

Emerald Health Therapeutics Launches Island Mist One of Canadas Highest CBD and CBD to THC Ratio Dried Flower Products

Monday, September 18, 2017

GLOBE NEWSWIRE

VICTORIA British Columbia Sept 18 2017 GLOBE NEWSWIRE Emerald Health Therapeutics Inc Therapeutics TSXVEMH OCTQXEMHTF has released Island Mist its proprietary high cannabidiol CBD and high CBD to THC ratio dried flower product This Indicadominant strain which came out of Emeralds broad seed ba..

Cytokinetics Announces Presentation of Additional Results From COSMICHF at the HFSA 21st Annual Scientific Meeting

Monday, September 18, 2017

GLOBE NEWSWIRE

SOUTH SAN FRANCISCO Calif Sept 18 2017 GLOBE NEWSWIRE Cytokinetics Incorporated NasdaqCYTK today announced that additional results from COSMICHF Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure a Phase 2 trial evaluating omecamtiv mecarbil in patients with chr..

CareTrust REIT Announces Quarterly Dividend of 0185 per Share

Monday, September 18, 2017

GLOBE NEWSWIRE

SAN CLEMENTE Calif Sept 18 2017 GLOBE NEWSWIRE CareTrust REIT Inc NASDAQCTRE announced today that its Board of Directors has declared a quarterly common stock cash dividend of 0185 per share payable on October 13 2017 to common stockholders of record as of the close of business on September 29..

Thermo Fisher Scientific Laboratory Freezers Earn US EPA ENERGY STAR Rating

Monday, September 18, 2017

Laboratories can now rely on Thermo Fisher Scientifics expanded line of coldstorage products to help them meet their goals for both productivity and sustainability The company recently earned the US Environmental Protection Agencys EPAs ENERGY STAR certification for its Thermo Scientific TSX Series ..

PIH Health Opens Urgent Care Centers to Bring the Right Level of Care to the Community

Monday, September 18, 2017

GLOBE NEWSWIRE

Whittier Calif Sept 18 2017 GLOBE NEWSWIRE Emergency room crowding continues to be an issue throughout the United States Providing the right level of care for nonemergent conditions in convenient community locations helps alleviate overcrowding in emergency rooms and enhance patients experienc..